Marisol Castillo-Castrejon1, Ivana V Yang2, Elizabeth J Davidson2, Sarah J Borengasser3, Purevsuren Jambal3, Jamie Westcott3, Jennifer F Kemp3, Ana Garces4, Sumera A Ali5, Sarah Saleem5, Robert L Goldenberg6, Lester Figueroa4, K Michael Hambidge3, Nancy F Krebs3, Theresa L Powell7. 1. Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 2. Biomedical Informatics & Personalized Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 3. Section of Nutrition, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 4. Maternal and Infant Health Center, Institute of Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala. 5. Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan. 6. Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA. 7. Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract
BACKGROUND: Preconceptional maternal small-quantity lipid-based nutrient supplementation (SQLNS) improved intrauterine linear growth in low-resource countries as demonstrated by the Women First Preconception Maternal Nutrition Trial (WF). Fetal growth is dependent on nutrient availability and regulated by insulin-like growth factor 1 (IGF-1) through changes in placental transfer capacity, mediated by the mechanistic target of rapamycin (mTOR) pathway. OBJECTIVES: Our objective was to evaluate the role of placental mTOR and IGF-1 signaling on fetal growth in women from 2 low-resource countries with high rates of stunting after they received preconceptional SQLNS. METHODS: We studied 48 women from preconception through delivery who were from Guatemala and Pakistan and received SQLNS or not, as part of the WF study. Placental samples were obtained at delivery (control, n = 24; SQLNS, n = 24). Placental protein or mRNA expression of eukaryotic translation initiation factor binding protein-1 (4E-BP1), ribosomal protein S6 (rpS6), AMP-activated protein kinase α (AMPKA), IGF-1, insulin-like growth factor receptor (IGF-1R), and pregnancy associated plasma protein (PAPP)-A, and DNA methylation of the IGF1 promoter were determined. Maternal serum IGF-1, insulin-like growth factor binding protein (IGFBP)-3, IGFBP-4, IGFBP-5, PAPP-A, PAPP-A2, and zinc were measured. RESULTS: Mean ± SEM maternal prepregnancy BMI differed between participants in Guatemala (26.5 ± 1.3) and Pakistan (19.8 ± 0.7) (P < 0.001). In Pakistani participants, SQLNS increased the placental rpS6(T37/46):rpS6 ratio (1.5-fold) and decreased the AMPKA(T172):AMPKA ratio. Placental IGF1 mRNA expression was positively correlated with birth length and birth weight z-scores. Placental PAPP-A (30-fold) and maternal serum zinc (1.2-fold) increased with SQLNS. In Guatemalan participants SQLNS did not influence placental mTOR signaling. Placental IGF-1R protein expression was positively associated with birth length and birth weight z-scores. SQLNS increased placental PAPP-A (40-fold) and maternal serum IGFBP-4 (1.6-fold). CONCLUSIONS: In Pakistani pregnant women with poor nutritional status, preconceptional SQLNS activated placental mTOR and IGF-1 signaling and was associated with improved fetal growth. In contrast, in Guatemalan women SQLNS did not activate placental nutrient-sensing pathways. In populations experiencing childhood stunting, preconceptional SQLNS improves placental function and fetal growth only in the context of poor maternal nutrition. This trial was registered at clinicaltrials.gov as NCT01883193.
BACKGROUND: Preconceptional maternal small-quantity lipid-based nutrient supplementation (SQLNS) improved intrauterine linear growth in low-resource countries as demonstrated by the Women First Preconception Maternal Nutrition Trial (WF). Fetal growth is dependent on nutrient availability and regulated by insulin-like growth factor 1 (IGF-1) through changes in placental transfer capacity, mediated by the mechanistic target of rapamycin (mTOR) pathway. OBJECTIVES: Our objective was to evaluate the role of placental mTOR and IGF-1 signaling on fetal growth in women from 2 low-resource countries with high rates of stunting after they received preconceptional SQLNS. METHODS: We studied 48 women from preconception through delivery who were from Guatemala and Pakistan and received SQLNS or not, as part of the WF study. Placental samples were obtained at delivery (control, n = 24; SQLNS, n = 24). Placental protein or mRNA expression of eukaryotic translation initiation factor binding protein-1 (4E-BP1), ribosomal protein S6 (rpS6), AMP-activated protein kinase α (AMPKA), IGF-1, insulin-like growth factor receptor (IGF-1R), and pregnancy associated plasma protein (PAPP)-A, and DNA methylation of the IGF1 promoter were determined. Maternal serum IGF-1, insulin-like growth factor binding protein (IGFBP)-3, IGFBP-4, IGFBP-5, PAPP-A, PAPP-A2, and zinc were measured. RESULTS: Mean ± SEM maternal prepregnancy BMI differed between participants in Guatemala (26.5 ± 1.3) and Pakistan (19.8 ± 0.7) (P < 0.001). In Pakistani participants, SQLNS increased the placental rpS6(T37/46):rpS6 ratio (1.5-fold) and decreased the AMPKA(T172):AMPKA ratio. Placental IGF1 mRNA expression was positively correlated with birth length and birth weight z-scores. Placental PAPP-A (30-fold) and maternal serum zinc (1.2-fold) increased with SQLNS. In Guatemalan participantsSQLNS did not influence placental mTOR signaling. Placental IGF-1R protein expression was positively associated with birth length and birth weight z-scores. SQLNS increased placental PAPP-A (40-fold) and maternal serum IGFBP-4 (1.6-fold). CONCLUSIONS: In Pakistani pregnant women with poor nutritional status, preconceptional SQLNS activated placental mTOR and IGF-1 signaling and was associated with improved fetal growth. In contrast, in Guatemalan womenSQLNS did not activate placental nutrient-sensing pathways. In populations experiencing childhood stunting, preconceptional SQLNS improves placental function and fetal growth only in the context of poor maternal nutrition. This trial was registered at clinicaltrials.gov as NCT01883193.
Authors: K Michael Hambidge; Leland V Miller; Manolo Mazariegos; Jamie Westcott; Noel W Solomons; Victor Raboy; Jennifer F Kemp; Abhik Das; Norman Goco; Ty Hartwell; Linda Wright; Nancy F Krebs Journal: J Nutr Date: 2017-04-19 Impact factor: 4.798
Authors: Saleh H Alwasel; Abdul-Halaim Harrath; Jamal S Aljarallah; Zeinab Abotalib; Clive Osmond; S Y Al Omar; Kent Thornburg; David J P Barker Journal: Am J Hum Biol Date: 2013-05-09 Impact factor: 1.937
Authors: K Michael Hambidge; Nancy F Krebs; Jamie E Westcott; Ana Garces; Shivaprasad S Goudar; Balachandra S Kodkany; Omrana Pasha; Antoinette Tshefu; Carl L Bose; Lester Figueroa; Robert L Goldenberg; Richard J Derman; Jacob E Friedman; Daniel N Frank; Elizabeth M McClure; Kristen Stolka; Abhik Das; Marion Koso-Thomas; Shelly Sundberg Journal: BMC Pregnancy Childbirth Date: 2014-03-20 Impact factor: 3.007
Authors: Nancy F Krebs; K Michael Hambidge; Jamie L Westcott; Ana L Garcés; Lester Figueroa; Antoinette K Tshefu; Adrien L Lokangaka; Shivaprasad S Goudar; Sangappa M Dhaded; Sarah Saleem; Sumera Aziz Ali; Melissa S Bauserman; Richard J Derman; Robert L Goldenberg; Abhik Das; Dhuly Chowdhury Journal: Am J Clin Nutr Date: 2022-07-06 Impact factor: 8.472